Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Biopsy Impact on Fibrosis in Marginal Renal Transplant
NCT00817687Phase 4Completed
- Sponsor
- Roche
- Start
- Jan 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil in kidney transplantation (2 arms), sponsored by Roche. Primary endpoint: Proportion of patients with >=25% increase in fibrosis score at 52 weeks. Started Jan 2009; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00817687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00817687.